Familial hypercholesterolaemia trials in Greece

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia

  Where

  Ioannina, Thessaloniki

  Age

  Up to 17 years

  People

  8 worldwide

  Run by

  Novartis Pharma AG

  See details and how to join2024-514595-41-00 · EU 2024-514595-41-00
• Phase 3Taking people
  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Where

  Athens

  Age

  2 years to 100 years

  People

  195 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT05682378
• Phase 3Taking people
  Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  Where

  Ioannina, Thessaloniki

  Age

  2 years to 11 years

  People

  9 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06597006
• Phase 3Taking people
  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Where

  Athens, Ioannina

  Age

  6 years to 11 years

  People

  60 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06597019